Eagle Pharmaceuticals
EGRX
#10665
Rank
HK$25.77 M
Marketcap
HK$1.96
Share price
0.00%
Change (1 day)
-89.60%
Change (1 year)

Market capitalization of Eagle Pharmaceuticals (EGRX)

Market cap: HK$25.77 Million

As of June 2026 Eagle Pharmaceuticals has a market cap of HK$25.77 Million. This makes Eagle Pharmaceuticals the world's 10665th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Eagle Pharmaceuticals from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$25.77 M-43.2%
2025HK$45.37 M-18%
2024HK$55.33 M-89.57%
2023HK$0.53 B-82.15%
2022HK$2.97 B-42.03%
2021HK$5.12 B9%
2020HK$4.70 B-26.24%
2019HK$6.37 B45.28%
2018HK$4.38 B-29.51%
2017HK$6.22 B-34.59%
2016HK$9.52 B-11.4%
2015HK$10.74 B536.79%
2014HK$1.68 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
HK$4.542 T 17,627,080.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$2.288 T 8,879,109.05%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
HK$7.915 T 30,715,125.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$1.501 T 5,827,865.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$914.04 B 3,546,563.80%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$833.29 B 3,233,245.93%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
HK$315.93 B 1,225,784.82%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel